Alluvi (https://alluvicare.uk.com) Retatrutide is arguably the most discussed compound on the platform. Engineered as a triple agonist capable of interacting with GLP-1, GIP, and glucagon receptors, retatrutide is studied to understand how simultaneous modulation of multiple metabolic pathways might influence energy expenditure, glucose handling, and lipid metabolism.